PA
IBCP icon

PharVision Advisers’s Independent Bank Corp IBCP Stock Holding History

PharVision Advisers’s Portfolio IBCP Stock Details IBCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,268
Closed -$256K – 835
2025
Q3 		$256K Buy
+8,268
New +$267K 0.14% 318

Other funds holding IBCP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

PharVision Advisers's IBCP Position: Q4 2025 in Review

PharVision Advisers sold out of Independent Bank Corp (IBCP) in Q4 2025, closing a stake of 8,268 shares — an estimated $256K sold.

PharVision Advisers first reported a position in IBCP in Q3 2025 and held it in 1 quarter. The position peaked at $256K in Q3 2025. 179 funds tracked by Wall St. Rank hold IBCP as of Q4 2025.

  • PharVision Advisers reported no remaining Independent Bank Corp position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 8,268 Independent Bank Corp shares in Q4 2025, an estimated $256K.
  • PharVision Advisers first reported a position in Independent Bank Corp in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Independent Bank Corp position peaked at $256K in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Independent Bank Corp as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.